>> Black Swan Analysis Blog

Black Swan Analysis Blog

PROVIDING COMMERCIALISATION SUPPORT TO A UNIVERSITY INTELLECTUAL PROPERTY GROUP

On November 22, 2017, Tags Case Studies

Brief

An invention at a major academic institution has the potential to be useful in screening and profiling patients with a variety of conditions. The goal is to identify both the potential use, and...

MARKET ACCESS AND OUTCOMES MODELLING FOR PHASE II ASSET

On November 22, 2017, Tags Case Studies

Brief

Myocardial revascularisation is a life-saving intervention for patients suffering myocardial infarction (MI). However, tissue damage associated with revascularisation of the heart muscle...

MARKET EVALUATION OF OTC AND POM MEDICATION MARKET FOR BIOTECHNOLOGY FIRM

On November 22, 2017, Tags Case Studies

Brief

A small biotech firm with a novel chewable technology was looking to assess the global market for their technology. An understanding and quantification of both over-the-counter (OTC) and...

QUANTIFYING THE MARKET POTENTIAL FOR A NEW PHARMACEUTICAL GRADE DIAGNOSTIC IMAGING AGENT

On November 22, 2017, Tags Case Studies

Brief

There is currently no industry standard database for Europe that identifies the location of PET/CT imaging sites and potential commercial cyclotron manufacturing sites. Unlike the US, the...

PAN-EUROPEAN STANDARDISATION OF FORECASTING PLATFORM

On November 22, 2017, Tags Case Studies

Brief

A global biopharmaceutical company is seeking to standardise the forecasting approach used in their core European markets. There is currently no consistent format, structure or coverage across...

ASIAN MARKET EXPANSION FOR NEW INFECTIOUS DISEASE TREATMENT

On November 22, 2017, Tags Case Studies

Brief

A global biopharmaceutical company is currently seeking approval to launch a new drug in several Asian countries for the treatment of a chronic, and endemic, infectious disease. Many of these...

CONCEPT TESTING OF AN INNOVATIVE IMAGING PLATFORM

On November 22, 2017, Tags Case Studies

Brief

A market leading device manufacturer is in the process of developing the next generation of imaging technology. The designs are currently at a conceptual stage with the product profile being...

PATIENT-BASED MODEL TO CHALLENGE PRE-EXISTING EVALUATION OF A NOVEL THERAPEUTIC FOR A POPULATION WITH HIGH UNMET MEDICAL NEED

On November 22, 2017, Tags Case Studies

Brief

A global biotechnology company had previously assessed the potential acquisition of a product with a novel mechanism of action, for use within a niche population with high unmet medical need....

Avid Radiopharmaceuticals, Vice-President Sales & Marketing - Testimonial

On November 20, 2017, Tags Testimonial
“I was really impressed by the work that Black Swan had produced for us. They quickly understood the complexity of the opportunity our product could deliver, carried out a thorough analysis and...

Gilead Sciences, International Commercial Strategy - Testimonial

On November 20, 2017, Tags Testimonial
“Black Swan helped our company to not only map out the patient journey, but identified leverage points for change. It was a logical user-friendly model interface which utilised all available data...
New Call-to-action

Subscribe to Email Updates

New call-to-action
RX Brochure CTA Large

Recent Posts

Free Brochure Epiomic